Aussie patients wait for homegrown therapy
By Megan Brodie 1 month ago | In Companies, Products, Regulatory- 1 month ago
26 August 2026 An Australian company with a ground breaking therapy for a rare disease…
This is subscriber-only content. Please login to continue reading.
One response
Comments are closed.
An Australian based company that appears not to have made the effort to apply for TGA registration – yet has apparently received Australian tax-payer financial incentives. Not only does it say a lot about the company’s real values but makes me question how tax-free arrangements should be designed in future!